Mesenchymal stromal cells protect combined oncolytic and helper-dependent adenoviruses from humoral immunity
Systemic delivery of oncolytic and immunomodulatory adenoviruses may be required for optimal effects on human malignancies. Mesenchymal stromal cells (MSCs) can serve as delivery systems for cancer therapeutics due to their ability to transport and shield these agents while homing to tumors. We now...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2024-09-01
|
| シリーズ: | Molecular Therapy: Methods & Clinical Development |
| 主題: | |
| オンライン・アクセス: | http://www.sciencedirect.com/science/article/pii/S2329050124000950 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
